Each component contributes a distinct mechanism: BPC-157 supports angiogenesis and cytoprotection, TB-500 (Thymosin Beta-4 fragment) drives cellular migration, GHK-Cu activates extracellular matrix synthesis and gene expression remodeling, and KPV (Lys-Pro-Val) the C-terminal tripeptide of -MSH provides targeted anti-inflammatory activity at the gut and tissue level
ProHealth extends this architecture by adding both a postbiotic (directly delivered butyrate via ButyroGen) and a peptide (BPC-157) that pre-clinical animal research suggests may support the gastrointestinal environment - a mechanism the brand describes based on its own published references, not as an established human clinical outcome
BPC-157 works by encouraging new blood vessel formation (angiogenesis), boosting collagen production for healthier connective tissues, and reducing inflammation, thereby assisting in the healing of tendons, ligaments, and muscles
This graduated approach allows your body to adjust to increased growth hormone signaling without overwhelming the pituitary axis
| 03.13.26 | 9 min read
Modulates NAD+ and methylation pathways